Selected research
Industry Research
Taxifolin Industry Research Report 2026
Market perspective
The global Taxifolin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Taxifolin is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Taxifolin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Taxifolin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Taxifolin include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Taxifolin market in revenue (US$ million) and, where applicable, sales volume (KG), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/KG) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Taxifolin.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Taxifolin Market by Company
Ametis JSC
JW Health Products
Kalenika Group
Hefei Lifeon Pharma
ROBIOS
Kingherbs Ltd
Beton Nutrition Corporation
Xi'an Sost Biotech Co.,Ltd
Taxifolin Segment by Type
Below 92%
92%-98%
Above 98%
Taxifolin Segment by Application
Food and Beverages
Healthcare
Cosmetics
Agriculture
Others
Taxifolin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taxifolin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taxifolin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taxifolin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Taxifolin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Taxifolin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Taxifolin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 92%
- 92%-98%
- Above 98%
Applications
- Food and Beverages
- Healthcare
- Cosmetics
- Agriculture
- Others
Companies covered
- Ametis JSC
- JW Health Products
- Kalenika Group
- Hefei Lifeon Pharma
- ROBIOS
- Kingherbs Ltd
- Beton Nutrition Corporation
- Xi'an Sost Biotech Co.,Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Taxifolin by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Below 92%
- 2.2.3 92%-98%
- 2.2.4 Above 98%
- 2.3 Taxifolin by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Food and Beverages
- 2.3.3 Healthcare
- 2.3.4 Cosmetics
- 2.3.5 Agriculture
- 2.3.6 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Taxifolin Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Taxifolin Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Taxifolin Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Taxifolin Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Taxifolin Production by Manufacturers (2021-2026)
- 3.2 Global Taxifolin Production Value by Manufacturers (2021-2026)
- 3.3 Global Taxifolin Average Price by Manufacturers (2021-2026)
- 3.4 Global Taxifolin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Taxifolin Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Taxifolin Manufacturers, Product Type & Application
- 3.7 Global Taxifolin Manufacturers Established Date
- 3.8 Global Taxifolin Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ametis JSC
- 4.1.1 Ametis JSC Taxifolin Company Information
- 4.1.2 Ametis JSC Taxifolin Business Overview
- 4.1.3 Ametis JSC Taxifolin Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Ametis JSC Product Portfolio
- 4.1.5 Ametis JSC Recent Developments
- 4.2 JW Health Products
- 4.2.1 JW Health Products Taxifolin Company Information
- 4.2.2 JW Health Products Taxifolin Business Overview
- 4.2.3 JW Health Products Taxifolin Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 JW Health Products Product Portfolio
- 4.2.5 JW Health Products Recent Developments
- 4.3 Kalenika Group
- 4.3.1 Kalenika Group Taxifolin Company Information
- 4.3.2 Kalenika Group Taxifolin Business Overview
- 4.3.3 Kalenika Group Taxifolin Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Kalenika Group Product Portfolio
- 4.3.5 Kalenika Group Recent Developments
- 4.4 Hefei Lifeon Pharma
- 4.4.1 Hefei Lifeon Pharma Taxifolin Company Information
- 4.4.2 Hefei Lifeon Pharma Taxifolin Business Overview
- 4.4.3 Hefei Lifeon Pharma Taxifolin Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Hefei Lifeon Pharma Product Portfolio
- 4.4.5 Hefei Lifeon Pharma Recent Developments
- 4.5 ROBIOS
- 4.5.1 ROBIOS Taxifolin Company Information
- 4.5.2 ROBIOS Taxifolin Business Overview
- 4.5.3 ROBIOS Taxifolin Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 ROBIOS Product Portfolio
- 4.5.5 ROBIOS Recent Developments
- 4.6 Kingherbs Ltd
- 4.6.1 Kingherbs Ltd Taxifolin Company Information
- 4.6.2 Kingherbs Ltd Taxifolin Business Overview
- 4.6.3 Kingherbs Ltd Taxifolin Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Kingherbs Ltd Product Portfolio
- 4.6.5 Kingherbs Ltd Recent Developments
- 4.7 Beton Nutrition Corporation
- 4.7.1 Beton Nutrition Corporation Taxifolin Company Information
- 4.7.2 Beton Nutrition Corporation Taxifolin Business Overview
- 4.7.3 Beton Nutrition Corporation Taxifolin Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Beton Nutrition Corporation Product Portfolio
- 4.7.5 Beton Nutrition Corporation Recent Developments
- 4.8 Xi'an Sost Biotech Co.,Ltd
- 4.8.1 Xi'an Sost Biotech Co.,Ltd Taxifolin Company Information
- 4.8.2 Xi'an Sost Biotech Co.,Ltd Taxifolin Business Overview
- 4.8.3 Xi'an Sost Biotech Co.,Ltd Taxifolin Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Xi'an Sost Biotech Co.,Ltd Product Portfolio
- 4.8.5 Xi'an Sost Biotech Co.,Ltd Recent Developments
5 Global Taxifolin Production by Region
- 5.1 Global Taxifolin Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Taxifolin Production by Region: 2021-2032
- 5.2.1 Global Taxifolin Production by Region: 2021-2026
- 5.2.2 Global Taxifolin Production Forecast by Region (2027-2032)
- 5.3 Global Taxifolin Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Taxifolin Production Value by Region: 2021-2032
- 5.4.1 Global Taxifolin Production Value by Region: 2021-2026
- 5.4.2 Global Taxifolin Production Value Forecast by Region (2027-2032)
- 5.5 Global Taxifolin Market Price Analysis by Region (2021-2026)
- 5.6 Global Taxifolin Production and Value, YOY Growth
- 5.6.1 North America Taxifolin Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Taxifolin Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Taxifolin Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Taxifolin Production Value Estimates and Forecasts (2021-2032)
6 Global Taxifolin Consumption by Region
- 6.1 Global Taxifolin Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Taxifolin Consumption by Region (2021-2032)
- 6.2.1 Global Taxifolin Consumption by Region: 2021-2026
- 6.2.2 Global Taxifolin Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Taxifolin Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Taxifolin Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Taxifolin Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Taxifolin Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Taxifolin Production by Type (2021-2032)
- 7.1.1 Global Taxifolin Production by Type (2021-2032) & (KG)
- 7.1.2 Global Taxifolin Production Market Share by Type (2021-2032)
- 7.2 Global Taxifolin Production Value by Type (2021-2032)
- 7.2.1 Global Taxifolin Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Taxifolin Production Value Market Share by Type (2021-2032)
- 7.3 Global Taxifolin Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Taxifolin Production by Application (2021-2032)
- 8.1.1 Global Taxifolin Production by Application (2021-2032) & (KG)
- 8.1.2 Global Taxifolin Production Market Share by Application (2021-2032)
- 8.2 Global Taxifolin Production Value by Application (2021-2032)
- 8.2.1 Global Taxifolin Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Taxifolin Production Value Market Share by Application (2021-2032)
- 8.3 Global Taxifolin Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Taxifolin Value Chain Analysis
- 9.1.1 Taxifolin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Taxifolin Production Mode & Process
- 9.2 Taxifolin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Taxifolin Distributors
- 9.2.3 Taxifolin Customers
10 Global Taxifolin Analyzing Market Dynamics
- 10.1 Taxifolin Industry Trends
- 10.2 Taxifolin Industry Drivers
- 10.3 Taxifolin Industry Opportunities and Challenges
- 10.4 Taxifolin Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst